InBios' Lyme Detect™ Multiplex ELISA Demonstrates Potential to Streamline Lyme Disease Testing in New UConn Health Study

Data ReadoutpositiveLyme Detect™ Multiplex ELISAPositive

AI Analysis

Summary

InBios International announced that its Lyme Detect™ Multiplex ELISA demonstrated potential to streamline Lyme disease testing in a new UConn Health study using a single-step approach.

Outcome Details

Single-step ELISA approach demonstrates potential to streamline Lyme disease testing

Importance:5/10

Sentiment:

0.60

diagnosticsLyme diseaseELISAemerging infectious diseasesUConn Health collaboration

Related Companies

$ISCO $HIT

Read the original article

Published by PR Newswire Pharma on September 17, 2026 7:00 AM

Read Original